From atom to brain: Applications of molecular imaging to neurosurgery

World Neurosurgery

Volumn 73, Issue 5, 2010, Pages 477-485

  Taghva, Alexander ^a   Khalessi, Alexander A ^a   Kim, Paul E ^a   Liu, Charles Y ^a   Apuzzo, Michael L J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Functional neurosurgery; Molecular imaging; Nanotechnology; Neuropsychiatric disorders; Positron emission tomography; Quantum dots; Stereotactic neurosurgery

Indexed keywords

5,5 DIMETHYL 2,4 OXAZOLIDENEDONE C 11; 9 [4 HYDROXY 2 (HYDROXYMETHYL)BUTYL]GUANINE F 18; ALBUMIN C 11; ANTINEOPLASTIC AGENT; BETA CIT I 124; CARMUSTINE C 11; DOPAMINE RECEPTOR STIMULATING AGENT; FALLYPRIDE F 18; FLUORODEOXYGLUCOSE F 18; FLUOROMETHANE F 18; HSV1 TK; LEUCINE C 11; LOMUSTINE C 11; METHIONINE C 11; QUANTUM DOT; RACLOPRIDE; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TEMOZOLOMIDE C 11; UNCLASSIFIED DRUG; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; BENZAMIDE DERIVATIVE; DOPAMINE RECEPTOR; N-((1-ALLYL-2-PYRROLIDINYL)METHYL)-5-(3-FLUOROPROPYL)-2,3-DIMETHOXYBENZAMIDE; PYRROLIDINE DERIVATIVE;

BRAIN DEPTH STIMULATION; CANCER DIAGNOSIS; CANCER GENE THERAPY; CEREBROVASCULAR DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DRUG MONITORING; FUNCTIONAL NEUROSURGERY; GLIOBLASTOMA; HUMAN; LIPOSOMAL GENE DELIVERY SYSTEM; MOLECULAR IMAGING; NANOTECHNOLOGY; NEUROIMAGING; NEUROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; RECURRENT CANCER; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL TRANSPLANTATION; STEREOTAXIC SURGERY; ANATOMY AND HISTOLOGY; BRAIN; BRAIN NEOPLASMS; CEREBROVASCULAR DISORDERS; DIAGNOSTIC USE; METABOLISM; NEURODEGENERATIVE DISEASES; PROCEDURES; RADIOGRAPHY; RADIOSURGERY; SCINTISCANNING;

BENZAMIDES; BRAIN; BRAIN NEOPLASMS; CEREBROVASCULAR DISORDERS; DEMENTIA; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; NANOTECHNOLOGY; NEURODEGENERATIVE DISEASES; NEUROSURGERY; NEUROSURGICAL PROCEDURES; PYRROLIDINES; QUANTUM DOTS; RADIOPHARMACEUTICALS; RADIOSURGERY; RECEPTORS, DOPAMINE;

EID: 77957164841     PISSN: 18788750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.wneu.2010.02.058     Document Type: Article

References (35)

1. A. Abosch, S. Kapur, A.E. Lang, D. Hussey, E. Sime, J. Miyasaki, S. Houle, and A.M. Lozano Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release Neurosurgery 53 2003 1095 1102 discussion 1102-1095
2. A. Benazzouz, D. Gao, Z. Ni, and A.L. Benabid High frequency stimulation of the STN influences the activity of dopamine neurons in the rat Neuroreport 11 2000 1593 1596
3. T.M. Bliss, R.H. Andres, and G.K. Steinberg Optimizing the success of cell transplantation therapy for stroke Neurobiol Dis 2009
4. D.J. Brooks, and P. Piccini Imaging in Parkinson's disease: the role of monoamines in behavior Biol Psychiatry 59 2006 908 918
5. N. Bruet, F. Windels, A. Bertrand, C. Feuerstein, A. Poupard, and M. Savasta J Neuropathol Exp Neurol 60 2001 15 24
6. G.L. Cascini, A. Ciarmiello, A. Labate, S. Tamburrini, and A. Quattrone Unexpected detection of melanoma brain metastasis by PET with iodine-124 betaCIT Clin Nucl Med 34 2009 698 699
7. D.E. Ferrara, D. Weiss, P.H. Carnell, R.P. Vito, D. Vega, X. Gao, S. Nie, and W.R. Taylor Quantitative 3D fluorescence technique for the analysis of en face preparations of arterial walls using quantum dot nanocrystals and two-photon excitation laser scanning microscopy Am J Physiol Regul Integr Comp Physiol 290 2006 R114 R123
8. A.J. Fischman, and R.D. Badgaiyan Functional imaging of neurotransmission Curr Med Imag Rev 3 2007
9. L. Gao, Y. Hoi, D.D. Swartz, J. Kolega, A. Siddiqui, and H. Meng Nascent aneurysm formation at the basilar terminus induced by hemodynamics Stroke 39 2008 2085 2090
10. R. Hilker, J. Voges, M. Ghaemi, R. Lehrke, J. Rudolf, A. Koulousakis, K. Herholz, K. Wienhard, V. Sturm, and W.D. Heiss Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans Mov Disord 18 2003 41 48
11. A.R. Hsu, W. Cai, A. Veeravagu, K.A. Mohamedali, K. Chen, S. Kim, H. Vogel, L.C. Hou, V. Tse, M.G. Rosenblum, and X. Chen Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel J Nucl Med 48 2007 445 454
12. A. Jacobs, J. Voges, R. Reszka, M. Lercher, A. Gossmann, L. Kracht, C. Kaestle, R. Wagner, K. Wienhard, and W.D. Heiss Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas Lancet 358 2001 727 729
13. C. Kohler, H. Hall, S.O. Ogren, and L. Gawell Specific in vitro and in vivo binding of 3H-raclopride A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain Biochem Pharmacol 34 1985 2251 2259
14. J.N. Marsh, A. Senpan, G. Hu, M.J. Scott, P.J. Gaffney, S.A. Wickline, and G.M. Lanza Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis Nanomed 2 2007 533 543
15. R. Matsumoto, M. Ichise, H. Ito, T. Ando, H. Takahashi, Y. Ikoma, J. Kosaka, R. Arakawa, Y. Ota, M. Fujimura, A. Takano, K. Fukui, K. Nakayama, and T. Suhara Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study Neuroimage 49 2010 121 126
16. M.A. McAteer, J.E. Schneider, Z.A. Ali, N. Warrick, C.A. Bursill, C. von zur Muhlen, D.R. Greaves, S. Neubauer, K.M. Channon, and R.P. Choudhury Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide Arterioscler Thromb Vasc Biol 28 2008 77 83
17. M.A. McAteer, N.R. Sibson, C. von Zur Muhlen, J.E. Schneider, A.S. Lowe, N. Warrick, K.M. Channon, D.C. Anthony, and R.P. Choudhury In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide Nat Med 13 2007 1253 1258
18. J.H. Meyer Imaging the serotonin transporter during major depressive disorder and antidepressant treatment J Psychiatry Neurosci 32 2007 86 102
19. A.R. Rezai, A.G. Machado, M. Deogaonkar, H. Azmi, C. Kubu, and N.M. Boulis Surgery for movement disorders Neurosurgery 62 Suppl 2 2008 809 838 discussion 838-809
20. B.J. Schaller Strategies for molecular imaging dementia and neurodegenerative diseases Neuropsychiatr Dis Treat 4 2008 585 612
21. C. Scherfler, J. Schwarz, A. Antonini, D. Grosset, F. Valldeoriola, K. Marek, W. Oertel, E. Tolosa, A.J. Lees, and W. Poewe Role of DAT-SPECT in the diagnostic work up of parkinsonism Mov Disord 22 2007 1229 1238
22. A.P. Strafella, A.F. Sadikot, and A. Dagher Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease Neuroreport 14 2003 1287 1289
23. A. Taghva, P.E. Kim, C.Y. Liu, and M.L.J. Apuzzo Molecular imaging, part 1: apertures into the landscape of genomic medicine World Neurosurg 2010 307 316
24. I. Tracey, and M.C. Bushnell How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J Pain 10 2009 1113 1120
25. N.T. Vandehey, P.C. Garell, J.A. Hampel, D. Murali, E.M. Smith, R. Davidson, A.K. Converse, R.J. Nickles, and B.T. Christian PET measurement of changes in D2/D3 dopamine receptor binding in a nonhuman primate during chronic deep brain stimulation of the bed nucleus of the stria terminalis J Neurosci Methods 176 2009 129 135
26. M. Veiseh, P. Gabikian, S.B. Bahrami, O. Veiseh, M. Zhang, R.C. Hackman, A.C. Ravanpay, M.R. Stroud, Y. Kusuma, S.J. Hansen, D. Kwok, N.M. Munoz, R.W. Sze, W.M. Grady, N.M. Greenberg, R.G. Ellenbogen, and J.M. Olson Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci Cancer Res 67 2007 6882 6888
27. O. Veiseh, C. Sun, C. Fang, N. Bhattarai, J. Gunn, F. Kievit, K. Du, B. Pullar, D. Lee, R.G. Ellenbogen, J. Olson, and M. Zhang Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier Cancer Res 69 2009 6200 6207
28. O. Veiseh, C. Sun, J. Gunn, N. Kohler, P. Gabikian, D. Lee, N. Bhattarai, R. Ellenbogen, R. Sze, A. Hallahan, J. Olson, and M. Zhang Optical and MRI multifunctional nanoprobe for targeting gliomas Nano Lett 5 2005 1003 1008
29. A.D. Waldman, A. Jackson, S.J. Price, C.A. Clark, T.C. Booth, D.P. Auer, P.S. Tofts, D.J. Collins, M.O. Leach, and J.H. Rees Quantitative imaging biomarkers in neuro-oncology Nat Rev Clin Oncol 6 2009 445 454
30. R. Weissleder, H.C. Cheng, A. Bogdanova, and A. Bogdanov Jr Magnetically labeled cells can be detected by MR imaging J Magn Reson Imaging 7 1997 258 263
31. S.A. Wickline, A.M. Neubauer, P.M. Winter, S.D. Caruthers, and G.M. Lanza Molecular imaging and therapy of atherosclerosis with targeted nanoparticles J Magn Reson Imaging 25 2007 667 680
32. F. Wuest, T. Kniess, R. Bergmann, B. Henry, and J. Pietzsch Synthesis and radiopharmacological characterization of [11C]AL-438 as a nonsteroidal ligand for imaging brain glucocorticoid receptors Bioorg Med Chem Lett 17 2007 4035 4039
33. S.S. Yaghoubi, and S.S. Gambhir PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk reporter gene expression in mice and humans using [18F]FHBG Nat Protoc 1 2006 3069 3075
34. S.S. Yaghoubi, M.C. Jensen, N. Satyamurthy, S. Budhiraja, D. Paik, J. Czernin, and S.S. Gambhir Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma Nat Clin Pract Oncol 6 2009 53 58
35. W. Zitterl, M. Aigner, T. Stompe, K. Zitterl-Eglseer, K. Gutierrez-Lobos, T. Wenzel, G. Zettinig, K. Hornik, W. Pirker, and K. Thau Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder Neuropsychopharmacology 33 2008 3126 3134